9th – 11th September 2013

Past Attendees Include

Maria Lagerstrom-Fermer
Vincent Brichard
Patrick Chene
Gabriella Camboni
Fabien  Schmidlin
Henning Steinhagen
Maria Lagerstrom-Fermer
Vincent Brichard
Patrick Chene
Gabriella Camboni
Fabien  Schmidlin
Henning Steinhagen

The Summit

9th – 11th September 2013

NG30 Drug Discovery Europe

Summit Venue
Sheraton Mirasierra Hotel & Spa, Madrid

The Next Generation 30 Drugs Discovery Summit brings together 30 senior decision makers and business leaders from across the region.

  • Previous Summits

    No Previous Summits Available

More Videos

The NG30 Drug Discovery Europe brings together 30 senior decision makers and business leaders from across the region.

The event aims to solve your key business challenges. In particular, the ability to network and learn from industry peers through essential business conversation shaped by our three unique drivers of opportunity:

 

Research
We conduct comprehensive, first-class research

 

Engagement
We invite only the most senior representatives from the region's largest organisations

 

Environment
We provide an environment conducive to high-level networking and collaboration

 

This NG30 Drug Discovery Europe is invitation-only, if you would like to find out more about the program or attendees, please contact Oliver Smart.

Oliver Smart
Chief Executive Officer
M: (+44) 07824 644 713 (UK)
E: oliver.smart@gdsinternational.com

More info

When I was asked to participate in this event as a delegate, I was quite sceptical about the value of this event to me, my group and my company. However, this view has completely changed – the networking opportunities were excellent"

George Okafu, GSK

Key Topics

  • Personalised Medicine
  • Open Innovation
  • Late-Stage Attrition
View All

Solution Providers Include